Broker Tips
Peel Hunt downgrades Flutter Entertainment due to expected Covid-19 impact
Analysts at Peel Hunt downgraded their recommendation for shares of Flutter Entertainment following the shares' recent strong performance and after marking down its estimates for the sports betting gambling firm's earnings in 2021.
Broker tips: On the Beach, RyanAir, Beazley
Citi downgraded its stance on shares of package holiday provider On The Beach on Tuesday to 'neutral' from 'buy' following the 29% share price rise a day earlier on the back of positive news about Pfizer and BioNTech's Covid-19 vaccine.
Tuesday broker round-up
On the Beach: Citigroup downgrades to neutral with a target price of 370p.
Citi downgrades On The Beach after share price jump
Citi downgraded its stance on shares of package holiday provider On The Beach on Tuesday to ‘neutral’ from ‘buy’ following the 29% share price rise a day earlier on the back of positive news about Pfizer and BioNTech’s Covid-19 vaccine.
IAG and Easyjet will still need more liquidity in 2021, Morgan Stanley says
News of Pfizer and BioNTech's Covid-19 vaccine candidate's greater than 90% efficacy is positive for investor sentiment and reduces the probability of Morgan Stanley's 'bear case' ensuing, the broker said.
Positive vaccine news could drive up global growth expectations, says Goldman
Positive news flow on a Covid-19 vaccine is likely to boost risky assets further, Goldman Sachs said in a note on Tuesday, but in contrast to the initial US election relief, it has the potential to drive global growth expectations higher alongside lower uncertainty on the recovery.
Go 'overweight' cyclicals, UK set to benefit the most from vaccine news, Credit Suisse says
Things are looking up for equities, especially the UK, in the wake of the reported 90% efficacy of Pfizer's Covid-19 vaccine candidate, said equity strategists at Credit Suisse.
Barclays starts Beazley at 'overweight'
Barclays initiated coverage of Beazley at ‘overweight’ on Tuesday with a 391p price target, arguing that it’s "a rare example of a growth play in insurance".